Knocking down liver CCAAT/enhancer-binding protein α by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice

Endocrinology

Volumn 147, Issue 6, 2006, Pages 3060-3069

  Qiao, Liping ^a   MacLean, Paul S ^b   You, Hanning ^a   Schaack, Jerome ^b   Shao, Jianhua ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; BETA GALACTOSIDASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIC AMP; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN SYNTHASE; MESSENGER RNA; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; LIPOGENESIS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DIABETES MELLITUS; DNA-BINDING PROTEINS; GLUCONEOGENESIS; GLUCOSE; GLUCOSE-6-PHOSPHATASE; HOMEOSTASIS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PPAR ALPHA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; RNA, SMALL INTERFERING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS;

EID: 33646789794     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1507     Document Type: Article

References (38)

1. Johnson PF, Landschulz WH, Graves BJ, McKnight SL 1987 Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1:133-146
2. McKnight SL 2001 McBindall - a better name for CCAAT/enhancer binding proteins? Cell 107:259-261
3. Croniger C, Leahy P, Reshef L, Hanson RW 1998 C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver. J Biol Chem 273:31629-31632
4. Hanson RW 2005 Metabolism in the era of molecular biology. J Biol Chem 280:1705-1715
5. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG 1996 Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J Biol Chem 271:24753-24760
6. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ 1995 Impaired energy homeostasis in C/EBPα knockout mice. Science 269:1108-1112
7. Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ 2004 Disruption of hepatic C/EBP{α} results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem 279:44740-44748
8. Lee YH, Sauer B, Johnson PF, Gonzalez FJ 1997 Disruption of the c/ebp α gene in adult mouse liver. Mol Cell Biol 17:6014-6022
9. Yang J, Croniger CM, Lekstrom-Himes J, Zhang P, Fenyus M, Tenen DG, Darlington GJ, Hanson RW 2005 Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein α (C/EBPα). J Biol Chem 280:38689-38699
10. DeFronzo RA, Simonson D, Ferrannini E 1982 Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319
11. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D 1984 Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246
12. DeFronzo RA 1988 Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
13. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J 2005 C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B 1998 A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514
15. Orlicky DJ, Schaack J 2001 Adenovirus transduction of 3T3-L1 cells. J Lipid Res 42:460-466
16. Shao J, Qiao L, Janssen RC, Pagliassotti M, Friedman JE 2005 Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 54:976-984
17. Croniger CM, Millward C, Yang J, Kawai Y, Arinze IJ, Liu S, Harada-Shiba M, Chakravarty K, Friedman JE, Poli V, Hanson RW 2001 Mice with a deletion in the gene for CCAAT/enhancer-binding protein β have an attenuated response to cAMP and impaired carbohydrate metabolism. J Biol Chem 276:629-638
18. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M 1993 Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402
19. Roesler WJ, Khandelwal RL 1985 Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse. Diabetes 34:395-402
20. Lee CH, Olson P, Evans RM 2003 Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207
21. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF 2005 "New" hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1:309-322
22. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M 2004 PGC-1 promotes insulin resistance in liver through PPARα-dependent induction of TRB-3. Nat Med 10:530-534
23. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR 2000 Up-regulation of peroxisome proliferator-activated receptors (PPARα) and PPARγ messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPARγ-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021-4031
24. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138
25. Horton JD, Goldstein JL, Brown MS 2002 SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131
26. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM 2005 Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell 120:261-273
27. Darlington GJ, Ross SE, MacDougald OA 1998 The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273:30057-30060
28. Matsusue K, Gavrilova O, Lambert G, Brewer Jr HB, Ward JM, Inoue Y, LeRoith D, Gonzalez FJ 2004 Hepatic CCAAT/enhancer binding protein-α mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol Endocrinol 18:2751-2764
29. Croniger C, Trus M, Lysek-Stupp K, Cohen H, Liu Y, Darlington GJ, Poli V, Hanson RW, Reshef L 1997 Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. J Biol Chem 272:26306-26312
30. Chen SS, Chen JF, Johnson PF, Muppala V, Lee YH 2000 C/EBPβ, when expressed from the C/ebpα gene locus, can functionally replace C/EBPα in liver but not in adipose tissue. Mol Cell Biol 20:7292-7299
31. Hornbuckle LA, Everett CA, Martin CC, Gustavson SS, Svitek CA, Oeser JK, Neal DW, Cherrington AD, O'Brien RM 2004 Selective stimulation of G-6-Pase catalytic subunit but not G-6-Pase transporter gene expression by glucagon in vivo and cAMP in situ. Am J Physiol Endocrinol Metab 286:E795-E808
32. Chakravarty K, Cassuto H, Reshef L, Hanson RW 2005 Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 40:129-154
33. Roesler WJ 2000 What is a cAMP response unit? Mol Cell Endocrinol 162:1-7
34. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, Montminy M 2005 The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437:1109-1111
35. O'Brien RM, Lucas PC, Yamasaki T, Noisin EL, Granner DK 1994 Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through CCAAT/enhancer binding protein (C/EBP). J Biol Chem 269:30419-30428
36. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M 2001 CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179-183
37. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM 2003 Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature 423:550-555
38. Shimomura I, Bashmakov Y, Horton JD 1999 Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032